These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17689584)

  • 21. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
    Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice.
    Zheng BJ; Ng MH; Chan KW; Tam S; Woo PC; Ng SP; Yuen KY
    Eur J Immunol; 2002 Nov; 32(11):3294-304. PubMed ID: 12555675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
    Daemen T; Riezebos-Brilman A; Regts J; Dontje B; van der Zee A; Wilschut J
    Antivir Ther; 2004 Oct; 9(5):733-42. PubMed ID: 15535411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.
    Eiben GL; Velders MP; Schreiber H; Cassetti MC; Pullen JK; Smith LR; Kast WM
    Cancer Res; 2002 Oct; 62(20):5792-9. PubMed ID: 12384540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence.
    Fissolo N; Riedl P; Reimann J; Schirmbeck R
    Eur J Immunol; 2005 Jan; 35(1):117-27. PubMed ID: 15593127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
    Tine JA; Firat H; Payne A; Russo G; Davis SW; Tartaglia J; Lemonnier FA; Demoyen PL; Moingeon P
    Vaccine; 2005 Jan; 23(8):1085-91. PubMed ID: 15620483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of augmented immune responses in mouse by prime-and-boost immunization strategy with DNA vaccine coding HBsAg and rHBsAg protein.
    Wang Y; Li DA; Hey Y; Wang F; Guo YJ; Yang F; Zhou Q; Sun SH
    Vaccine; 2007 Nov; 25(48):8146-53. PubMed ID: 18029065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunogenicity of a multiple epitope DNA vaccine against hepatitis B virus].
    Luo LM; Li M; Xia H; Chen BH; Wang P; Hao WB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):517-21. PubMed ID: 15367337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
    Liang Z; Lan Y; Li Y; Cai D; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour.
    Herd KA; Harvey T; Khromykh AA; Tindle RW
    Virology; 2004 Feb; 319(2):237-48. PubMed ID: 14980484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTL responses to a DNA vaccine encoding E7 gene of human papillomavirus type 16 from an Iranian isolate.
    Meshkat Z; Soleimanjahi H; Mahmoudi M; Hassan ZM; Mirshahabi H; Meshkat M; Kheirandish M
    Iran J Immunol; 2008 Jun; 5(2):82-91. PubMed ID: 18523353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
    Herd KA; Wiethe C; Tindle RW
    Vaccine; 2007 Jul; 25(28):5209-19. PubMed ID: 17544551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
    Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
    J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model.
    Qian X; Lu Y; Liu Q; Chen K; Zhao Q; Song J
    Immunol Lett; 2006 Feb; 102(2):191-201. PubMed ID: 16242781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.
    Liu DW; Tsao YP; Kung JT; Ding YA; Sytwu HK; Xiao X; Chen SL
    J Virol; 2000 Mar; 74(6):2888-94. PubMed ID: 10684306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.